Fruent ® is a client-focused, philosophy driven consulting firm.  We specialize in U.S. and international IP and business strategies for companies in the biological, chemical, and medical device ecosystems.  We provide services to clients seeking to pursue their interests through the use of highly experienced professionals within each client’s field of specialization.  Since 2014, Fruent ® has been serving clients focused in the life sciences.  Fruent ® provides our clients with professional consulting services by working as a technical partner in creating strategy, product development, organization and sales to commercialize life science products and services.

The Fruent ® Team

Donald Fruge, B.S., MPH

CEO

Donald is the Founder and CEO of Fruent, a global life sciences consulting firm. He is the co-founder and Executive Director of Feeney Law Group, a global intellectual property law firm dedicated to the advancement of life sciences and technology innovations.  He is also the Executive Director of U.S. Operations for Toronto-based PCK IP.

Lars Wahlberg, M.D., PhD

Scientific Advisor, Senior Life Science Entrepreneur, Neurosurgeon, and Translational Scientist

Biotechnology entrepreneur, neurosurgeon, and translational scientist with 20 years of biotechnology R&D experience in developing biologics-based therapies for neurological disorders. Founder and CEO of Gloriana Therapeutics with successful track record in raising capital, grant funding, and partnership to move products from R&D into therapeutic product opportunities.

ROBERT PETCAVICH, PhD

Advisor, Innovative Process

Senior executive with more than 30 years experience within the life sciences, manufacturing, and service industries. Bob has 40 issued US patents and over 200 internationally pending and published in such fields as stem cells, human microbiome electronic packaging, stealth aerospace materials, microwave food packaging, degradable polymers, liquid crystal displays, touch screens, animal nutraceuticals, hydrocarbon recovery, self-assembled monolayers, and digital micro electrical mechanical systems (MEMS) biochip arrays.

Specialties: Human induced Pluripotent Stem Cell technologies, Touch Sensor Technologies, Nano and Micro Printing and Imprint Technologies, Polymers, Flexographic Printing, Medical RFID devices, Microwave Technologies, Thin Films, and Molecular Self Assembly

Bob is a results oriented and effective leader with proven ability to build organizations and create significant investor and shareholder value. Talent for recruiting and motivating professional teams, new product, market development, and raising growth capital. Demonstrated track record in the areas of:

Research and Development, Managing Innovation, Product Development, Strategic Planning, Team Building and Leadership, Intellectual Property Management, Board of Directors, Capital Raising, Pre/Post IPO management, Technology Start Ups

Diana Rich, B.A.

Chief of Business Development and Implementation

Barbara Rosengren

Alliance Management

Barbara’s professional experience includes various commercial and project management leadership positions as well as extensive Alliance Management experience. In addition to this biopharma experience, Barbara has served as a guest faculty instructor at the Massachusetts Biotechnology Council (MBC), the Harvard Extension School and the Brown Executive Master of Healthcare Leadership program.

http://www.fruent.co/barbara-rosengren/

John Diamantakos

Director of Visual Media